Rescreening Gets A Boost

Executive Summary

As Pap smear technology advances, lines are being drawn in the sand between product companies and their pathologist and physician customers. Neuromedical Systems' aggressive consumer marketing campaign warned women that Pap smears alone aren't enough to accurately diagnose cervical cancer, that the company's new rescreening technology. But physicians are up in arms, concerned that the company is getting them into potential liability troubles if they don't rescreeen.